See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: July 10, 2007

Prostate Cancer Pregnancy Asthma

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Prostate Cancer

This study will evaluate the effects of treating prostate cancer with androgen suppression for eight weeks, followed by radiation therapy. To qualify, you must have clinically or pathologically negative lymph nodes, no prior pelvic radiation therapy or cryosurgery for prostate cancer, and no metastatic disease.

The research site is in Poughkeepsie, N.Y.

More information

Please see http://www.centerwatch.com/patient/studies/cat36.html.

-----

Pregnancy

This study will evaluate the efficacy and safety of a low-dose birth control pill. To qualify, you must be at least 18, have regular menstrual cycles, and be willing to use the pill for 13 months. Participants will receive study related office visits, testing, and investigational birth control pill at no cost.

The research site is in Denver, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat187.html.

-----

Asthma

If you have asthma and still have symptoms despite treatment with high-dose Advair or similar asthma medication, you may qualify for this study of a combination therapy. You must be between ages 12 and 75, and unable to control allergic asthma with standard treatments. Participants will receive study related care and medication free of charge, and reimbursement for time and travel.

The research site is in Lexington, Ky.

More information

Please see http://www.centerwatch.com/patient/studies/cat16.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.